Sprint Bioscience
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hälsovägen 7, Huddinge, Stockholm, 141 5...Phone Number
+46 84114455Website
www.sprintbioscience.comRevenue
<$5 MillionStock Symbol
SPRINTIndustry
About Sprint Bioscience
Sprint Bioscience Org Chart
Administrative Assistant
Is Sprint Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sprint Bioscience has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sprint Bioscience has new funding data
Congratulate Masked Content for being promoted to Masked Content at Sprint Bioscience
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sprint Bioscience launches new products
Check out if Sprint Bioscience is spiking on competitors!
Sprint Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sprint Bioscience had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Sprint Bioscience recently announced quarterly report
Recommended Actions
Find VP level buyers at Sprint Bioscience
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sprint Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sprint Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sprint Bioscience.
Sprint Bioscience Tech Stack
A closer look at the technologies used by Sprint Bioscience
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sprint Bioscience
Sprint Bioscience is a pharmaceutical company focused on developing innovative drug candidates aimed at providing new treatment options for cancer. The company utilizes a fragment-based drug development approach to efficiently create drug programs that are licensed to global pharmaceutical companies during the preclinical phase. With a significant... Read More